An iron-binding drug that is already approved for treatment of other diseases could provide a novel way to attack ovarian tumors, according to a new study led by Weill Cornell Medicine researchers.

A drug that binds to iron and that has been FDA-approved for treating other conditions has shown promise in treating ovarian cancer in mouse models. Researchers are now designing human trials for the ...

Iron-chelating drugs bind tightly to iron, preventing cells from using it. To confirm the importance of iron in ovarian cancer, Dr. Cubillos-Ruiz's team first looked at a collection of human tumor ...

Longitudinal survey data from Mexico suggested that a so-called weekend warrior physical activity pattern was associated with a reduced risk of mild dementia. (British Journal of Sports Medicine) Also ...

CHELATION THERAPY HAS been around for decades as a treatment for toxic metal poisoning. But, there have also been claims that the therapy could help several other conditions. Experts aren't so sure.

An iron-binding drug that is already approved for treatment of other diseases could provide a novel way to attack ovarian tumors, according to a new study led by Weill Cornell Medicine researchers.